Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)
Date issued
2011Journal title
Journal of Thoracic Oncology
Type of content
Publicación de congreso